Study to evaluate the efficacy of Dhanyamla Dhara in Diabetic Neuropathy
Phase 1
- Conditions
- Health Condition 1: G64- Other disorders of peripheral nervous system
- Registration Number
- CTRI/2023/08/056952
- Lead Sponsor
- DR VAIDYANATH V.S
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Metabolically stable diabetic subjects with symptomatic Diabetic Peripheral Neuropathy.
2.Subjects of all gender between the age group of 30-65 years.
3.Subjects fulfilling the diagnostic criteria.
4.Subjects whose HbA1C is between 6.5 to 10%.
Exclusion Criteria
1.Subjects where HbA1C >10% and <6.5%.
2.Subjects suffering from Type-1 Diabetes or Gestational Diabetes.
3.Pregnant and lactating women.
4.Subjects suffering from infectious diseases and non-healing ulcer/ ulcers of foot.
5.Any systemic illness that can interfere with the course of treatment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessment of the patients condition will be done based on <br/ ><br>1.Changes in Michigan Neuropathy Screening Instrument (MNSI) Questionnaire score <br/ ><br>2.Changes in Toronto Neuropathy Clinical Scale (TCNS) Score <br/ ><br>3.Changes in Visual Analog Scale (VAS) <br/ ><br>Timepoint: Before intervention 0th day <br/ ><br>After intervention 7th day <br/ ><br>Follow up 14th day
- Secondary Outcome Measures
Name Time Method 1. Changes in FBS value <br/ ><br>2. Changes in PPBS valueTimepoint: Before intervention 0th day <br/ ><br>After intervention 7th day <br/ ><br>Follow up 14th day